| Dr Damanpaul Singh Sondhi, MD | |
|
1425 Portland Avenue, Rochester, NY 14621-3095 | |
| (585) 922-4409 | |
| (585) 922-4833 |
| Full Name | Dr Damanpaul Singh Sondhi |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 32 Years |
| Location | 1425 Portland Avenue, Rochester, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437199015 | NPI | - | NPPES |
| 02534274 | Medicaid | NY | |
| RB6022 | Other | NY | MEDICARE TELEMEDICINE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 218619 (New York) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 218619 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rochester General Hospital | Rochester, NY | Hospital |
| Newark-wayne Community Hospital | Newark, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rochester General Hospital | 0244149474 | 891 |
News Archive
Lockdown and social distancing measures are in place in many countries across the world, intended to stem the rapid spread of the coronavirus disease (COVID-19) global pandemic. These measures work by reducing the risk of viral transmission in communities, reducing the burden of the healthcare system in dealing with the surge of patients, overwhelming its resources and workforce. Now, experts warn that these social distancing measures may still be needed until 2022.
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery-; successfully fixing donated immune cells from a 16-year-old boy with an abnormally low level of white blood cells called lymphopenia.
IBM today announced that it has signed a business process services agreement with athenahealth, Inc. a leading provider of Internet-based business services for physician practices. The engagement will enable athenahealth to focus its resources on simplifying and improving administrative and reimbursement processes while reducing staff workload, allowing physicians to focus on delivering higher quality care to their patients.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
| Entity Name | Rochester General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356412712 PECOS PAC ID: 0244149474 Enrollment ID: O20031121000644 |
News Archive
Lockdown and social distancing measures are in place in many countries across the world, intended to stem the rapid spread of the coronavirus disease (COVID-19) global pandemic. These measures work by reducing the risk of viral transmission in communities, reducing the burden of the healthcare system in dealing with the surge of patients, overwhelming its resources and workforce. Now, experts warn that these social distancing measures may still be needed until 2022.
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery-; successfully fixing donated immune cells from a 16-year-old boy with an abnormally low level of white blood cells called lymphopenia.
IBM today announced that it has signed a business process services agreement with athenahealth, Inc. a leading provider of Internet-based business services for physician practices. The engagement will enable athenahealth to focus its resources on simplifying and improving administrative and reimbursement processes while reducing staff workload, allowing physicians to focus on delivering higher quality care to their patients.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
| Entity Name | Newark Wayne Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770671182 PECOS PAC ID: 0446154199 Enrollment ID: O20031212000722 |
News Archive
Lockdown and social distancing measures are in place in many countries across the world, intended to stem the rapid spread of the coronavirus disease (COVID-19) global pandemic. These measures work by reducing the risk of viral transmission in communities, reducing the burden of the healthcare system in dealing with the surge of patients, overwhelming its resources and workforce. Now, experts warn that these social distancing measures may still be needed until 2022.
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery-; successfully fixing donated immune cells from a 16-year-old boy with an abnormally low level of white blood cells called lymphopenia.
IBM today announced that it has signed a business process services agreement with athenahealth, Inc. a leading provider of Internet-based business services for physician practices. The engagement will enable athenahealth to focus its resources on simplifying and improving administrative and reimbursement processes while reducing staff workload, allowing physicians to focus on delivering higher quality care to their patients.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
| Entity Name | The Unity Hospital Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760421713 PECOS PAC ID: 9436060969 Enrollment ID: O20031230000038 |
News Archive
Lockdown and social distancing measures are in place in many countries across the world, intended to stem the rapid spread of the coronavirus disease (COVID-19) global pandemic. These measures work by reducing the risk of viral transmission in communities, reducing the burden of the healthcare system in dealing with the surge of patients, overwhelming its resources and workforce. Now, experts warn that these social distancing measures may still be needed until 2022.
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery-; successfully fixing donated immune cells from a 16-year-old boy with an abnormally low level of white blood cells called lymphopenia.
IBM today announced that it has signed a business process services agreement with athenahealth, Inc. a leading provider of Internet-based business services for physician practices. The engagement will enable athenahealth to focus its resources on simplifying and improving administrative and reimbursement processes while reducing staff workload, allowing physicians to focus on delivering higher quality care to their patients.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
| Entity Name | Clifton Springs Sanitarium Co |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366505463 PECOS PAC ID: 5092704809 Enrollment ID: O20040525000569 |
News Archive
Lockdown and social distancing measures are in place in many countries across the world, intended to stem the rapid spread of the coronavirus disease (COVID-19) global pandemic. These measures work by reducing the risk of viral transmission in communities, reducing the burden of the healthcare system in dealing with the surge of patients, overwhelming its resources and workforce. Now, experts warn that these social distancing measures may still be needed until 2022.
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery-; successfully fixing donated immune cells from a 16-year-old boy with an abnormally low level of white blood cells called lymphopenia.
IBM today announced that it has signed a business process services agreement with athenahealth, Inc. a leading provider of Internet-based business services for physician practices. The engagement will enable athenahealth to focus its resources on simplifying and improving administrative and reimbursement processes while reducing staff workload, allowing physicians to focus on delivering higher quality care to their patients.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
| Entity Name | Western New York Medical Practice Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063790608 PECOS PAC ID: 3870767791 Enrollment ID: O20111110000598 |
News Archive
Lockdown and social distancing measures are in place in many countries across the world, intended to stem the rapid spread of the coronavirus disease (COVID-19) global pandemic. These measures work by reducing the risk of viral transmission in communities, reducing the burden of the healthcare system in dealing with the surge of patients, overwhelming its resources and workforce. Now, experts warn that these social distancing measures may still be needed until 2022.
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery-; successfully fixing donated immune cells from a 16-year-old boy with an abnormally low level of white blood cells called lymphopenia.
IBM today announced that it has signed a business process services agreement with athenahealth, Inc. a leading provider of Internet-based business services for physician practices. The engagement will enable athenahealth to focus its resources on simplifying and improving administrative and reimbursement processes while reducing staff workload, allowing physicians to focus on delivering higher quality care to their patients.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Damanpaul Singh Sondhi, MD 1425 Portland Avenue, Rochester, NY 14621-3095 Ph: (585) 922-4409 | Dr Damanpaul Singh Sondhi, MD 1425 Portland Avenue, Rochester, NY 14621-3095 Ph: (585) 922-4409 |
News Archive
Lockdown and social distancing measures are in place in many countries across the world, intended to stem the rapid spread of the coronavirus disease (COVID-19) global pandemic. These measures work by reducing the risk of viral transmission in communities, reducing the burden of the healthcare system in dealing with the surge of patients, overwhelming its resources and workforce. Now, experts warn that these social distancing measures may still be needed until 2022.
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery-; successfully fixing donated immune cells from a 16-year-old boy with an abnormally low level of white blood cells called lymphopenia.
IBM today announced that it has signed a business process services agreement with athenahealth, Inc. a leading provider of Internet-based business services for physician practices. The engagement will enable athenahealth to focus its resources on simplifying and improving administrative and reimbursement processes while reducing staff workload, allowing physicians to focus on delivering higher quality care to their patients.
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.
› Verified 6 days ago
Amy Bodrog, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4020 Fax: 585-922-4622 | |
Natalia Golub, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Hagen Dr Ste 320, Rochester, NY 14625 Phone: 585-922-1900 | |
Hanan Ibrahim Sheikh Ibrahim, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 200, Rochester, NY 14621 Phone: 585-922-0390 Fax: 585-922-0395 | |
Numra Aslam Bajwa, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 716-862-1871 | |
Dr. Prakash Upreti, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 295-029-8769 | |
William M Valenti, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 259 Monroe Avenue, Rochester, NY 14607 Phone: 585-545-7200 Fax: 585-244-6456 | |
Ms. Terri Winter, N.P. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 250 Crittenden Blvd, Box 617, Rochester, NY 14642 Phone: 585-275-2662 Fax: 585-276-0149 |